Opus Genetics Statistics
NASDAQ: IRDHealth CareBiotechnology: Pharmaceutical PreparationsUSD
3.99-0.09 (-2.21%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Opus Genetics by the numbers
Opus Genetics has a market capitalization of $385.7 million based on 96.65M shares outstanding. With trailing EPS of $-1.48, Opus Genetics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 8.3% below its 50-day average and 7.3% below its 200-day average.
Average daily trading volume is 2.56M shares, or about $10.2 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
IRD valuation vs. peer median
| Metric | IRD | Peer median | Difference |
|---|---|---|---|
| Market cap | $385.65M | $384.85M | +0% |
| Avg. volume | 2.56M | 1.44M | +77% |
Peer median across 8 companies: AVTX, PHAT, OCS, PBYI, ASPE, PEPG, OVID, CRMD.
Valuation
- Market cap
- $385.65M
- Price / sales (latest FY)
- 27.17
- EPS (TTM)
- $-1.48
- Shares outstanding
- 96.65M
Price and trading
- Previous close
- 4.08
- Open
- 4.01
- Day range
- 3.89 – 4.05
- 52-week range
- 1.88 – 7.07
- 52-week change
- +108.90%
- Beta
- —
- Volume
- 1.19M
- Average volume
- 2.56M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 10, 2026
Additional statistics
- Market Cap
- 385.65M
- Forward Pe
- -5.29
- Eps
- -1.48
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 7.07
- Week52 Low
- 1.88
- Avg Volume
- 2.56M
- Shares Outstanding
- 96.65M
- Ma50
- 4.35
- Ma200
- 4.30
- Earnings Date
- Nov 10, 2026
- Pct From52w High
- -43.56%
- Pct From52w Low
- 112.23%